People · Operator

Eric Flagg Donnenfeld

Named in public records as an officer, director or promoter · active 2008–2008 · Other Health Care

1
Companies
1
Filings
$31.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
TrueVision Systems IncOther Health CareSeries A$31.1M$185.9M2008
Operator network

Eric Flagg Donnenfeld at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Kevin Foley · 8 companies · 1 sharedKevin FoleyJ. Flagg Flanagan · 4 companies · 1 sharedJ. Flagg FlanaganArthur J. Rice III · 3 companies · 1 sharedArthur J. Rice IIIFrederick W Gluck · 3 companies · 1 sharedFrederick W GluckForrest Fleming · 2 companies · 1 sharedForrest FlemingKevin Flagg Foley · 2 companies · 1 sharedKevin Flagg FoleySimon Flagg Raab · 2 companies · 1 sharedSimon Flagg RaabSimon Raab · 2 companies · 1 sharedSimon RaabAidan A. Foley · 1 companies · 1 sharedAidan A. FoleyAidan Flagg Foley · 1 companies · 1 sharedAidan Flagg FoleyAidan J. Foley · 1 companies · 1 sharedAidan J. FoleyArthur J. Rice · 1 companies · 1 sharedArthur J. RiceMichael A. Weissman · 1 companies · 1 sharedMichael A. Weissm…TrueVision Systems Inc · $31.1M raisedTrueVision Systems IncEric Flagg DonnenfeldED
Eric Flagg Donnenfeld Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Eric Flagg Donnenfeld on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Kevin Foley18
J. Flagg Flanagan14
Frederick W Gluck13
Arthur J. Rice III13
Simon Raab12
Kevin Flagg Foley12
Simon Flagg Raab12
Forrest Fleming12
Michael A. Weissman11
Aidan Flagg Foley11
Aidan A. Foley11
Aidan J. Foley11
Arthur J. Rice11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.